The use of stereotactic radiotherapy with CyberKnife (Accuray Incorporated, Sunnyvale, CA) in adults is becoming more and more established. For children, there is no such consensus and the appropriate approach to this type of treatment is still debated. In the meantime, there seems to be a number of certain pediatric cases in which the use of CyberKnife within very strict limits is potentially justified. Here, we report the feasibility of and acute tolerance to radiotherapy with CyberKnife using conventional fractionation in 5 children.
*Département Universitaire de Radiothérapie, CyberKnife Nord-Ouest, Centre Oscar Lambret, CLCC, Université Lille II
†Unité d'Oncologie Pédiatrique, Centre Oscar Lambret, CLCC, Lille
Researchers do not have any actual or potential conflicts of interest to declare
Reprints: Charlotte Peugniez, MD, Centre Oscar Lambret, 3 rue Frédéric Combemale 59000 Lille (e-mail: email@example.com).
Received for publication February 5, 2010; accepted March 28, 2010